Terns Pharmaceuticals (TERN) Eyes Expansion Beyond China Amid Strong Analyst Sentiment

Terns Pharmaceuticals, Inc. (NASDAQ:TERN) is included successful our database of the 11 Best Performing Stocks successful the Last 12 Months.

On January 16, 2026, Terns Pharmaceuticals, Inc. (NASDAQ:TERN) announced that it has made a strategical amendment to its Exclusive Option and License Agreement with Hansoh (Shanghai) Healthtech Co., Ltd. Through this move, the institution converted its anterior non-exclusive, royalty-free licence to definite patents into an exclusive, sublicensable, royalty-bearing, perpetual worldwide license, though not including the Hansoh Territory. The licence pertains to therapeutic products containing TERN-701 arsenic the sole progressive ingredient. The improvement helps the institution fortify its commercialization rights extracurricular China, Taiwan, Hong Kong, and Macau.

Under the amendment, Terns Pharmaceuticals, Inc. (NASDAQ:TERN) volition beryllium liable to wage Hansoh a one-time upfront licence interest of $1.0 cardinal and tiered royalties of 0.75%-1.25% connected yearly nett income of 701 Products. However, these liabilities volition beryllium taxable to reductions wherever applicable.

Meanwhile, successful the erstwhile month, Citizens revisited Terns Pharmaceuticals, Inc. (NASDAQ:TERN), raising its terms people from $35 to $57, portion reiterating an ‘Outperform’ rating. The bullish code reflected the interim Phase 1 CARDINAL ASH update that featured TERN-701’s best-in-class profile, precocious heavy molecular effect complaint successful 1L, and beardown enactment post-asciminib and ponatinib successful 2L.

Terns Pharmaceuticals, Inc. (NASDAQ:TERN) focuses connected processing small-molecule and operation therapies for NASH, oncology, and chronic liver disease. Its clinical-stage programs span FXR, VAP-1, THR-β, and GLP-1 targets.

While we admit the imaginable of TERN arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: What Are the Best Stocks to Buy Right Now? and 10 Stocks Under $1 That Will Explode.

Disclosure: None.